New York State Teachers Retirement System (NYSTRS)’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,395
| Closed | -$400K | – | 1611 |
|
|
2023
Q2 | $400K | Sell |
15,395
-100
| -0.6% | -$2.68K | ﹤0.01% | 1447 |
|
|
2023
Q1 | $445K | Sell |
15,495
-400
| -3% | -$11.9K | ﹤0.01% | 1432 |
|
|
2022
Q4 | $470K | Hold |
15,895
| – | – | ﹤0.01% | 1421 |
|
|
2022
Q3 | $378K | Buy |
15,895
+100
| +0.6% | +$2.3K | ﹤0.01% | 1434 |
|
|
2022
Q2 | $353K | Buy |
15,795
+100
| +0.6% | +$2.23K | ﹤0.01% | 1453 |
|
|
2022
Q1 | $394K | Hold |
15,695
| – | – | ﹤0.01% | 1460 |
|
|
2021
Q4 | $562K | Hold |
15,695
| – | – | ﹤0.01% | 1409 |
|
|
2021
Q3 | $668K | Hold |
15,695
| – | – | ﹤0.01% | 1393 |
|
|
2021
Q2 | $679K | Hold |
15,695
| – | – | ﹤0.01% | 1377 |
|
|
2021
Q1 | $640K | Sell |
15,695
-800
| -5% | -$30.3K | ﹤0.01% | 1392 |
|
|
2020
Q4 | $747K | Sell |
16,495
-600
| -4% | -$22.8K | ﹤0.01% | 1338 |
|
|
2020
Q3 | $605K | Sell |
17,095
-1,600
| -9% | -$57.8K | ﹤0.01% | 1327 |
|
|
2020
Q2 | $705K | Sell |
18,695
-46
| -0.2% | -$1.52K | ﹤0.01% | 1281 |
|
|
2020
Q1 | $542K | Sell |
18,741
-500
| -3% | -$20.2K | ﹤0.01% | 1261 |
|
|
2019
Q4 | $998K | Buy |
19,241
+6,175
| +47% | +$359K | ﹤0.01% | 1266 |
|
|
2019
Q3 | $717K | Buy |
13,066
+1,900
| +17% | +$97.6K | ﹤0.01% | 1289 |
|
|
2019
Q2 | $454K | Hold |
11,166
| – | – | ﹤0.01% | 1376 |
|
|
2019
Q1 | $338K | Hold |
11,166
| – | – | ﹤0.01% | 1435 |
|
|
2018
Q4 | $375K | Hold |
11,166
| – | – | ﹤0.01% | 1398 |
|
|
2018
Q3 | $471K | Hold |
11,166
| – | – | ﹤0.01% | 1414 |
|
|
2018
Q2 | $357K | Hold |
11,166
| – | – | ﹤0.01% | 1462 |
|
|
2018
Q1 | $555K | Hold |
11,166
| – | – | ﹤0.01% | 1382 |
|
|
2017
Q4 | $602K | Hold |
11,166
| – | – | ﹤0.01% | 1376 |
|
|
2017
Q3 | $648K | Hold |
11,166
| – | – | ﹤0.01% | 1356 |
|
|
2017
Q2 | $551K | Sell |
11,166
-3,400
| -23% | -$157K | ﹤0.01% | 1376 |
|
|
2017
Q1 | $633K | Hold |
14,566
| – | – | ﹤0.01% | 1358 |
|
|
2016
Q4 | $713K | Sell |
14,566
-1,400
| -9% | -$64.7K | ﹤0.01% | 1351 |
|
|
2016
Q3 | $764K | Buy |
15,966
+1,900
| +14% | +$93.9K | ﹤0.01% | 1323 |
|
|
2016
Q2 | $755K | Buy |
14,066
+2,900
| +26% | +$137K | ﹤0.01% | 1337 |
|
|
2016
Q1 | $499K | Buy |
11,166
+800
| +8% | +$32.5K | ﹤0.01% | 1404 |
|
|
2015
Q4 | $396K | Buy |
10,366
+300
| +3% | +$11.5K | ﹤0.01% | 1435 |
|
|
2015
Q3 | $320K | Hold |
10,066
| – | – | ﹤0.01% | 1467 |
|
|
2015
Q2 | $332K | Sell |
10,066
-4,300
| -30% | -$153K | ﹤0.01% | 1471 |
|
|
2015
Q1 | $591K | Buy |
14,366
+700
| +5% | +$28.3K | ﹤0.01% | 1394 |
|
|
2014
Q4 | $557K | Buy |
13,666
+4,224
| +45% | +$165K | ﹤0.01% | 1406 |
|
|
2014
Q3 | $346K | Buy |
9,442
+489
| +5% | +$21.1K | ﹤0.01% | 1437 |
|
|
2014
Q2 | $415K | Buy |
8,953
+1,387
| +18% | +$61.7K | ﹤0.01% | 1432 |
|
|
2014
Q1 | $311K | Buy |
7,566
+1,700
| +29% | +$63.2K | ﹤0.01% | 1463 |
|
|
2013
Q4 | $224K | Buy |
+5,866
| New | +$181K | ﹤0.01% | 1482 |
|
Other funds holding ANIK
TI
CP
BFM
New York State Teachers Retirement System (NYSTRS)'s ANIK Position: Q3 2023 in Review
New York State Teachers Retirement System (NYSTRS) sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 15,395 shares — an estimated $400K sold.
New York State Teachers Retirement System (NYSTRS) first reported a position in ANIK in Q4 2013 and held it in 39 quarters. The position peaked at $998K in Q4 2019. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.
- New York State Teachers Retirement System (NYSTRS) reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
- New York State Teachers Retirement System (NYSTRS) sold 15,395 Anika Therapeutics shares in Q3 2023, an estimated $400K.
- New York State Teachers Retirement System (NYSTRS) first reported a position in Anika Therapeutics in Q4 2013 and held it in 39 quarters.
- New York State Teachers Retirement System (NYSTRS)'s Anika Therapeutics position peaked at $998K in Q4 2019.
- 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.
Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q3 2023, filed 25 Oct 2023.